scholarly article | Q13442814 |
P2093 | author name string | Passamani E | |
Morris HP | |||
Elford HL | |||
Freese M | |||
P433 | issue | 20 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 5228-5233 | |
P577 | publication date | 1970-10-01 | |
P1433 | published in | Journal of Biological Chemistry | Q867727 |
P1476 | title | Ribonucleotide reductase and cell proliferation. I. Variations of ribonucleotide reductase activity with tumor growth rate in a series of rat hepatomas | |
P478 | volume | 245 |
Q35533521 | 3,4-Dihydroxy-benzohydroxamic acid (Didox) suppresses pro-inflammatory profiles and oxidative stress in TLR4-activated RAW264.7 murine macrophages |
Q36465960 | A phase 1 and pharmacokinetic study of didox: a ribonucleotide reductase inhibitor |
Q35981425 | A phase I and pharmacokinetic study of didox administered by 36 hour infusion. The Cancer Research Campaign Phase I/II Clinical Trials Committee |
Q33382443 | A phase I study of Triapine in combination with doxorubicin in patients with advanced solid tumors |
Q33402598 | A phase I study of prolonged infusion of triapine in combination with fixed dose rate gemcitabine in patients with advanced solid tumors |
Q33697512 | Antimalarial activities of polyhydroxyphenyl and hydroxamic acid derivatives |
Q46326805 | Antitumor effects of KITC, a new resveratrol derivative, in AsPC-1 and BxPC-3 human pancreatic carcinoma cells. |
Q57909898 | Biochemical and antitumor activity of trimidox, a new inhibitor of ribonucleotide reductase |
Q36761745 | Broad overexpression of ribonucleotide reductase genes in mice specifically induces lung neoplasms |
Q26851312 | Cancer cells with irons in the fire |
Q86845997 | Control of Ehrlich cell division by zinc |
Q40501093 | Cytidine 5′-diphosphate reductase activity in phytohemagglutinin stimulated human lymphocytes |
Q36922559 | Differential effect of nucleoside analog triphosphates on ribonucleotide reductases from uninfected and herpes simplex virus-infected HeLa cells |
Q41751891 | Effect of ribonucleotide reductase inhibitors on the growth of human colon carcinoma HT-29 cells in culture |
Q34663999 | Effects of iron depletion on CALM-AF10 leukemias. |
Q91686303 | Erastin, a ferroptosis-inducing agent, sensitized cancer cells to X-ray irradiation via glutathione starvation in vitro and in vivo |
Q24616065 | Evaluation of mRNA by Q-RTPCR and protein expression by AQUA of the M2 subunit of ribonucleotide reductase (RRM2) in human tumors |
Q35348485 | Exploring the anti-cancer activity of novel thiosemicarbazones generated through the combination of retro-fragments: dissection of critical structure-activity relationships |
Q26822694 | From scourge to cure: tumour-selective viral pathogenesis as a new strategy against cancer |
Q33844465 | Functional interaction between fluorodeoxyuridine-induced cellular alterations and replication of a ribonucleotide reductase-negative herpes simplex virus |
Q37329773 | Glutathione-dependent hydrogen donor system for calf thymus ribonucleoside-diphosphate reductase |
Q39961878 | Growth-rate-dependent regulation of the expression and inactivation of thymidylate synthase in Saccharomyces cerevisiae |
Q67253501 | Hydroxyurea-resistant mouse L cells with elevated levels of drug-resistant ribonucleotide reductase activity |
Q33927768 | Hydroxyurea-resistant vaccinia virus: overproduction of ribonucleotide reductase |
Q37594412 | Increased expression of RRM2 by human papillomavirus E7 oncoprotein promotes angiogenesis in cervical cancer |
Q36338771 | Increased tRNA modification and gene-specific codon usage regulate cell cycle progression during the DNA damage response |
Q34699623 | Induction of a Reductive Pathway for Deoxyribonucleotide Synthesis during Early Embryogenesis of the Sea Urchin |
Q50877836 | Inhibition of ribonucleotide reductase and growth of human colon carcinoma HT-29 cells and mouse leukemia L1210 cells by N-hydroxy-N'-aminoguanidine derivatives. |
Q64100449 | Iron and Ferritin Modulate MHC Class I Expression and NK Cell Recognition |
Q37479772 | Iron chelators target both proliferating and quiescent cancer cells. |
Q37177365 | Iron deprivation in cancer--potential therapeutic implications |
Q38372890 | Microbial siderophores and their potential applications: a review |
Q36392883 | Multienzyme complex for metabolic channeling in mammalian DNA replication |
Q35343132 | Overproduction of the free radical of ribonucleotide reductase in hydroxyurea-resistant mouse fibroblast 3T6 cells |
Q33329120 | Phase I and pharmacologic study of oral (E)-2'-deoxy-2'-(fluoromethylene) cytidine: on a daily x 5-day schedule |
Q33658330 | Phase I trial of pelvic radiation, weekly cisplatin, and 3-aminopyridine-2-carboxaldehyde thiosemicarbazone (3-AP, NSC #663249) for locally advanced cervical cancer |
Q80059427 | Phase II study of Triapine in patients with metastatic renal cell carcinoma: a trial of the National Cancer Institute of Canada Clinical Trials Group (NCIC IND.161) |
Q41846912 | Phase II trial of didox in advanced breast cancer. Cancer Research Campaign Phase I/II Clinical Trials Committee |
Q33392476 | Phase II trial of the ribonucleotide reductase inhibitor 3-aminopyridine-2-carboxaldehydethiosemicarbazone plus gemcitabine in patients with advanced biliary tract cancer |
Q70284517 | Regulation of ribonucleotide reductase activity in mammalian cells |
Q42880827 | Ribonucleotide reductase activity in vitamin B12-deficient Euglena gracilis |
Q38218536 | Ribonucleotide reductase and cancer: biological mechanisms and targeted therapies |
Q36812510 | Ribonucleotide reductase association with mammalian liver mitochondria |
Q41761628 | Ribonucleotide reductase inhibitors reduce atherosclerosis in a double-injury rabbit model |
Q53572106 | Stabilization of SV40 transformed human fibroblast cytoplasmic thymidine kinase by ATP. |
Q28369082 | Synergistic anti-human immunodeficiency virus type 1 effect of hydroxamate compounds with 2',3'-dideoxyinosine in infected resting human lymphocytes |
Q35078434 | Targeted oncolytic herpes simplex virus type 1 eradicates experimental pancreatic tumors. |
Q93081083 | The Antitumor Didox Acts as an Iron Chelator in Hepatocellular Carcinoma Cells |
Q33426135 | The Eltrombopag antitumor effect on hepatocellular carcinoma |
Q38166287 | The potential of nucleotide analogs as inhibitors of retroviruses and tumors |
Q33632176 | Vaccinia virus-encoded ribonucleotide reductase subunits are differentially required for replication and pathogenesis |
Search more.